Not Found
On Demand

Controversies in Thyroidology: Advanced Pediatric Thyroid Cancer – Treatment Controversies


Duration:
1 Hour 01 Minutes
Format:
Audio and Video


Description

Our seventh of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. 


Program Details

This course includes a live Q&A session with faculty. Join the July 31, 2020 12:00 PM ET broadcast to be a part of the live Q&A session or post July 31 watch this program on-demand and receive 1.0 credit until August 31, 2021. View the Accreditation Statement/Credit tab for additional details.

Controversies in Thyroidology: Advanced Pediatric Thyroid Cancer – Treatment Controversies

Moderator: Jonathan D. Wasserman, MD

Faculty: Adina Alazraki, MD, FAAP, Steven G. Waguespack, MD, and Ari J. Wassner, MD

Learning Objectives:

  • To review the epidemiology of thyroid carcinoma in children with attention to those with advanced disease.

  • To highlight areas where the approach to distal disease in children may differ from that in adults.

  • To consider the role of tumour genomics in prognostication and treatment planning.

  • To discuss indications for and timing of systemic therapy for children with advanced disease.


Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/


Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).

 

Credits

Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement 

Drs. Jonathan Wasserman and Steve Waguespack are consultants for Bayer. Drs. Steve Waguespack and Ari Wassner intend to reference off-label/unapproved uses of products or devices. All other faculty did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices.

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  1.00 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021




Faculty

Jonathan Wasserman, MD Phd's Profile

Jonathan Wasserman, MD Phd Related seminars and products: 2

Staff Endocrinologist

Hospital For Sick Children


Jonathan D. Wasserman, MD, PhD is an Associate Professor of Pediatrics at the University of Toronto and a Staff Endocrinologist at The Hospital for Sick Children. He completed his PhD in Developmental Biology at the University of Cambridge and his MD at Harvard University & Massachusetts Institute of Technology.  He has an active clinical practice with a focus on pediatric endocrine malignancies and in endocrine care of childhood cancer survivors.  His research focuses on pediatric thyroid carcinoma using both translational and health services research methodologies. He is an active member of the American Thyroid Association, Canadian Pediatric Endocrine Group and the Pediatric Endocrine Society.


Steven Waguespack's Profile

Steven Waguespack Related seminars and products: 2

The University of Texas MD Anderson Cancer Center


Steven G. Waguespack, MD is a Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston. Board certified in both adult and pediatric endocrinology and recognized as one of "America's Top Doctors for Cancer" in endocrinology, his major clinical and research interests are thyroid cancer, hereditary endocrine tumor syndromes, and pituitary tumors. He is an active member of the American Thyroid Association (ATA), serves on the medical advisory council of ThyCa (Thyroid Cancer Survivors’ Association, Inc.), and has participated in the Thyroid Carcinoma Panel of the NCCN Clinical Practice Guidelines in Oncology. Furthermore, he served as a member of the ATA task force that revised the medullary thyroid cancer guidelines in 2015 and was a co-chair of the inaugural 2015 ATA guidelines for pediatric thyroid nodules and thyroid cancer.


Ari Wassner's Profile

Ari Wassner Related seminars and products: 2

Boston Children's Hospital


Ari J. Wassner is Medical Director of the Thyroid Center at Boston Children’s Hospital and Assistant Professor of Pediatrics at Harvard Medical School. He earned his MD from Harvard Medical School and completed Pediatric residency followed by fellowship in Pediatric Endocrinology at Boston Children’s Hospital. Dr. Wassner’s clinical specialty is in pediatric thyroid disease with a particular focus on thyroid neoplasia in children and on congenital hypothyroidism, and he is actively engaged in clinical research in these areas.  He is a member of the American Thyroid Association and serves on the ATA Pediatric Thyroid Cancer Guidelines Task Force. Dr. Wassner is also Director of the Endocrinology fellowship training program at Boston Children’s Hospital, and he is extensively involved in medical education and curriculum development at Harvard Medical School.


Adina Alazraki's Profile

Adina Alazraki Related seminars and products: 2

Emory University School of Medicine


Adina Alazraki, MD, FAAP is an Associate Professor of Radiology and Pediatrics at Emory University School of Medicine and also serves as the Director of Nuclear Medicine at Children’s Healthcare of Atlanta at Egleston. She has been practicing for 12 years with extensive training in body imaging and Nuclear medicine. She completed her undergraduate degree at the University of California, San Diego and received her medical degree from Emory University Medical School.  She has been invited to speak and publish on both pediatric body MRI and nuclear medicine including MIBG therapy for neuroblastoma on a national level. She built the body MRI program in pediatrics as well as the PET/CT service and I-131-MIBG therapy programs at Children’s Healthcare of Atlanta, Egleston. She also serves as Co-President of the Southern Pediatric Radiological Society.


Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement 

Drs. Jonathan Wasserman and Steve Waguespack are consultants for Bayer. Drs. Steve Waguespack and Ari Wassner intend to reference off-label/unapproved uses of products or devices. All other faculty did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices.

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  1.00 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021

Please wait ...

Back to Top